Form 4: Allstate CEO Thomas J. Wilson Executes Stock and Option Transactions
SEC Form 4 Filing
Allstate's CEO, Thomas J. Wilson, engaged in multiple transactions involving the company's stock and options, including sales, transfers, and option exercises, as detailed in a recent SEC filing.
Summary
- Thomas J. Wilson, CEO of Allstate, executed several transactions involving Allstate common stock and derivative securities on November 22, 2024.
- These transactions included the sale of 6,660 shares at an average price of $203.0289, 22,243 shares at $203.6096, and 2,600 shares at $204.5956.
- Wilson also transferred 43,022 shares from the 2022-B GRAT Trust to the 2020 GRAT Remainder Trust and distributed 65,321 shares to direct ownership, which were then contributed to the 2024-C GRAT Trust.
- Additionally, there were transfers of employee stock options to various TJW Options LLC series, and some options were exercised.
- The transactions were conducted under a Rule 10b5-1 trading plan adopted on August 22, 2024.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing detailing insider transactions. It does not contain any information that would significantly impact the company's outlook or investor sentiment.
Risks
- The document does not explicitly state any risks, but the sale of shares by the CEO could be interpreted negatively by the market if not understood in the context of a pre-arranged trading plan.
Industry Context
This filing is a routine disclosure of insider transactions and is common for executives of publicly traded companies. The use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading.
Comparison to Industry Standards
- The use of Rule 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the insurance sector like Progressive and Travelers.
- The reported stock sales and option exercises are typical for executive compensation and wealth management strategies.
- The use of GRAT trusts is a common estate planning tool for high-net-worth individuals, including corporate executives.
Stakeholder Impact
- The transactions are unlikely to have a significant impact on stakeholders, as they are part of a pre-arranged trading plan and do not indicate a change in the company's fundamentals.
Key Dates
| Date | Description |
|---|---|
| 02/09/2020 | Date of exercisability for some employee stock options. |
| 02/22/2021 | Date of exercisability for some employee stock options. |
| 02/08/2022 | Date of exercisability for some employee stock options. |
| 02/17/2022 | Date of stock option award grant. |
| 02/16/2023 | Date of stock option award grant. |
| 02/18/2024 | Date of exercisability for some employee stock options. |
| 07/03/2024 | Start date of share acquisitions through the Shareowner Service Plus Plan. |
| 08/22/2024 | Date the Rule 10b5-1 trading plan was adopted. |
| 10/02/2024 | End date of share acquisitions through the Shareowner Service Plus Plan. |
| 11/22/2024 | Date of multiple stock and option transactions. |
| 11/26/2024 | Date of the SEC filing. |
Keywords
insider trading, stock options, stock sales, beneficial ownership, SEC Form 4, Allstate, Thomas J. Wilson, Rule 10b5-1, GRAT Trust
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.